Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of YAZ for Contraception
NCT00185484Phase 3Completed
- Sponsor
- Bayer
- Start
- Mar 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in unintended pregnancy, sponsored by Bayer. Started Mar 2004; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on NCT00185484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185484.